Publications by authors named "Neal Hermanowicz"

Claim this Profile
I
Impact of Isolation During the COVID-19 Pandemic on the Patient Burden of Parkinson's Disease: A PMD Alliance Survey.
Neal Hermanowicz, Maria Cristina Ospina, Yasar Torres-Yaghi, Sherrie Gould, Kelly Papesh

Neuropsychiatr Dis Treat· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult Abdominal Migraine Improved by OnabotulinumtoxinA Injections.
Neal Hermanowicz

Case Rep Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration.
Thomas Klopstock, Aleksandar Videnovic, Almut Turid Bischoff, Cecilia Bonnet, Laura Cif, Neal Hermanowicz

Mov Disord· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's disease.
Michelle Paff, Alice S Wang, Nicolas Phielipp, Sumeet Vadera, Anna Morenkova, Neal Hermanowicz

J Robot Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing and addressing footwear needs in Parkinson's disease-design thinking in neurology.
Jamasb Sayadi, Lohrasb Ross Sayadi, Arman Fijany, Mustafa Chopan, Neal Hermanowicz

NeuroRehabilitation· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKG Movement Recording System Use Shows Promise in Routine Clinical Care of Patients With Parkinson's Disease.
Rajeshree Joshi, Jeffrey M Bronstein, A Keener, Jaclyn Alcazar, Diane D Yang, Neal Hermanowicz

Front Neurol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey.
Neal Hermanowicz, Sarah A Jones, Robert A Hauser

Neuropsychiatr Dis Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing the treatment paradigm for Parkinson's disease psychosis with pimavanserin.
Kelly E Lyons, Rajesh Pahwa, Neal Hermanowicz, Thomas Davis, Fernando Pagan

Expert Rev Clin Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician perceptions of disease management in Parkinson's disease: results from a US-based multicenter survey.
Neal Hermanowicz, Michelle Castillo-Shell, Angela McMean, Jesse Fishman, Joseph D'Souza

Neuropsychiatr Dis Treat· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurological commentary addressing the article titled "Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus".
Neal Hermanowicz

CNS Spectr· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delusional misidentification in Parkinson's disease: report of two cases and a review.
Neal Hermanowicz

Postgrad Med· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Role of Pimavanserin in the Management of Parkinson's Disease Psychosis.
Neal Hermanowicz, Gustavo Alva, Fernando Pagan, Alberto J Espay, Amita Patel

J Manag Care Spec Pharm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective.
Stuart H Isaacson, Stanley Fisher, Fiona Gupta, Neal Hermanowicz, Daniel E Kremens

Expert Rev Neurother· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frameless Stereotactic Robot-Assisted Subthalamic Nucleus Deep Brain Stimulation: Case Report.
Sumeet Vadera, Alvin Chan, Thomas Lo, Amandip Gill, Anna Morenkova, Neal Hermanowicz

World Neurosurg· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Andrew McGarry, Michael McDermott, Karl Kieburtz, Elisabeth A de Blieck, Flint Beal, Neal Hermanowicz

Neurology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety, tolerability and efficacy of pimavanserin tartrate in the treatment of psychosis in Parkinson's disease.
Stefan Hermanowicz, Neal Hermanowicz

Expert Rev Neurother· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
Neal Hermanowicz, Aaron Ellenbogen, Gordon Irving, Mark Buchfuhrer, Mark J Jaros

CNS Drugs· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of prior exposure to dopamine agonists on treatment with gabapentin enacarbil in adults with moderate-to-severe primary restless legs syndrome: pooled analyses from 3 randomized trials.
William G Ondo, Neal Hermanowicz, Diego García Borreguero, Mark J Jaros, Richard Kim

J Clin Mov Disord· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal surgery in Parkinson's disease--outcomes and predictors of mortality.
Grace S Hwang, Monica T Young, Mark H Hanna, Gopal Menon, Michael Phelan, Neal Hermanowicz

Int J Colorectal Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson's disease psychosis: symptoms, management, and economic burden.
Neal Hermanowicz, Kari Edwards

Am J Manag Care· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

JAMA Neurol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.
Marylou V Solbrig, Yijun Fan, Neal Hermanowicz, Maria Grazia Morgese, Andrea Giuffrida

Exp Neurol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of glyceraldehyde-3-phosphate dehydrogenase activity by antibodies present in the cerebrospinal fluid of patients with multiple sclerosis.
Johanna Kölln, Yiping Zhang, Gaby Thai, Michael Demetriou, Neal Hermanowicz

J Immunol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
Kelly E Lyons, Joseph H Friedman, Neal Hermanowicz, Stuart H Isaacson, Robert A Hauser

Clin Neuropharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased prevalence of val(66)met BDNF genotype among subjects with cervical dystonia.
Steven C Cramer, Ajay Sampat, Maureen Haske-Palomino, Shawn Nguyen, Vincent Procaccio, Neal Hermanowicz

Neurosci Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis